Top

Current Addiction Reports

Published in:

01-06-2017 | Alcohol (R Leeman, Section Editor)

Co-use of Alcohol and Opioids

Authors: Karlyn A. Edwards, Kevin E. Vowles, Katie Witkiewitz

Published in: Current Addiction Reports | Issue 2/2017

Abstract

Purpose of Review

This paper provides a narrative review of the co-use of alcohol and opioids, and its impact on biological, neurocognitive, and behavioral systems. In addition, data addressing co-use among patients receiving opioid replacement therapy and those who have chronic pain are discussed.

Recent Findings

Alcohol and opioids are among the most commonly used substances, and co-use has contributed to a growing number of accidental poisonings, emergency room visits, and overdose deaths. Prevalence of co-use is high among multiple populations and severely impacts treatment outcomes.

Summary

Treatment for those that co-use alcohol and opioids is inadequate. Future research should further investigate salient influences on co-use and identify potential targets for intervention to address this treatment need.

Hughes A, Williams MR, Lipari RN, Bose J, Copello E, Krout LA. Prescription Drug Use and Misuse in the United States: Results from the 2015 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration. http://www.samhsa.gov/data/sites/default/files/NSDUH-FFR2–2015/NSDUH-FFR2–2015.htm. Published 2015. Accessed January 1, 2016.

Daubresse M, Chang H, Yu Y, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000–2010. Med Care. 2013;51:870–8.CrossRefPubMed

Kreek MJ. Opioid interactions with alcohol. Adv Alcohol Subst Abus. 1984;3(4):35–46.CrossRef

White JM, Irvine RJ, White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94(7):961–72.CrossRefPubMed

Jones CM, Paulozzi LJ, Mack KA. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse—Related Emergency Department Visits and Drug-Related Deaths—United States, 2010. Morb Mortal Wkly Rep. 2014;63(40):881-11.

Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131(3):263–70. doi:10.1016/j.drugalcdep.2012.11.018.CrossRefPubMedPubMedCentral

Earleywine M, Newcomb MD. Concurrent versus simultaneous polydrug use: prevalence, correlates, discriminant validity, and prospective effects on health outcomes. Exp Clin Psychopharmacol. 1997;5(4):353–64.CrossRefPubMed

•• McCabe SE, Cranford JA, Morales M, Young A. Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. J Stud Alcohol. 2006;67:529–37. Alcohol and opioid concurrent use is associated with more drug and alcohol related problems than singular substance users, even after statistically controlling for frequency of substance use. CrossRefPubMedPubMedCentral

Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Heal. 1999;23(1):40–54. doi:10.1086/250095.

10.

Jobski K, Schmid U, Behr S, Andersohn F, Garbe E. 3-year prevalence of alcohol-related disorders in German patients treated with high-potency opioids. Pharmacoepidemiol Drug Saf. 2012;21(April):1125–9. doi:10.1002/pds.CrossRefPubMed

11.

Peacock A, Bruno R, Larance B, et al. Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: a retrospective 7-day diary study. Drug Alcohol Depend. 2016;166:125–33. doi:10.1016/j.drugalcdep.2016.07.003.CrossRefPubMed

12.

Larance B, Campbell G, Peacock A, et al. Pain, alcohol use disorders and risky patterns of drinking among people with chronic non-cancer pain receiving long-term opioid therapy. Drug Alcohol Depend. 2016;162:79–87. doi:10.1016/j.drugalcdep.2016.02.048.CrossRefPubMed

13.

Saunders KW, Von Korff M, Campbell CI, et al. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012;13(3):266–75. doi:10.1016/j.jpain.2011.11.004.CrossRefPubMedPubMedCentral

14.

McCabe SE, West BT, Teter CJ, Boyd CJ. Co-ingestion of prescription opioids and other drugs among high school seniors : results from a national study. Drug Alcohol Depend. 2012;126:65–70. doi:10.1016/j.drugalcdep.2012.04.017.CrossRefPubMedPubMedCentral

15.

McCabe SE, Cranford JA, West BT. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav. 2008;33:1297–305. doi:10.1016/j.addbeh.2008.06.005.CrossRefPubMedPubMedCentral

16.

Cushman P. Alcohol and opioids: possible interactions of clinical importance. Adv Alcohol Subst Abus. 1987;6(3):33–46.CrossRef

17.

Arias F, Arnsten JH, Cunningham CO, et al. Neurocognitive, psychiatric, and substance use characteristics in opioid dependent adults. Addict Behav. 2016;60:137–43. doi:10.1016/j.addbeh.2016.03.018.CrossRefPubMed

18.

• Baldacchino A, Balfour DJK, Passetti F, Humphris G, Matthews K. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehav Rev. 2012;36(9):2056–68. doi:10.1016/j.neubiorev.2012.06.006. Meta-analysis that shows a robust impairment in verbal working memory, cognitive impulsivity (risk taking) and cognitive flexibility (verbal fluency) among those who have had chronic opioid exposure. CrossRefPubMed

19.

Gudin JA, Mogali S, Jones JD, Comer SD. Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad Med. 2013;125(4):115–30. doi:10.3810/pgm.2013.07.2684.Risks.CrossRefPubMedPubMedCentral

20.

Khalili-mahani N, Zoethout RMW, Beckmann CF, et al. Effects of morphine and alcohol on functional brain connectivity during “resting state”: a placebo-controlled crossover study in healthy young men. Hum Brain Mapp. 2012;33(December 2010):1003–18. doi:10.1002/hbm.21265.CrossRefPubMed

21.

Garnier LM, Arria AM, Caldeira KM, Vincent KB, Grady KE, Wish ED. Nonmedical prescription analgesic use and concurrent alcohol consumption among college students. Am J Drug Alcohol Abuse. 2009;35(5):334–8. doi:10.1080/00952990903075059.CrossRefPubMedPubMedCentral

22.

Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8(7):573–82. doi:10.1016/j.jpain.2007.02.432.CrossRefPubMedPubMedCentral

23.

Gossop M, Marsden J, Stewart D. Dual dependence: assessment of dependence upon alcohol and illicit drugs, and the relationship of alcohol dependence among drug misusers to patterns of drinking, illicit drug use and health problems. Addiction. 2002;97(2):169–78. doi:10.1046/j.1360-0443.2002.00028.x.CrossRefPubMed

24.

Schepis TS, Hakes JK. Dose-related effects for the precipitation of psychopathology by opioid or tranquilizer/sedative nonmedical prescription use. J Addict Med. 2013;7(1):39–44. doi:10.1097/ADM.0b013e318277e9e5.CrossRefPubMed

25.

McCabe SE, Cranford JA, Boyd CJ. The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample. Drug Alcohol Depend. 2006;84:281–8. doi:10.1016/j.drugalcdep.2006.03.006.CrossRefPubMedPubMedCentral

26.

Hedden SL, Martins SS, Malcolm RJ, Floyd L, Cavanaugh CE, Latimer WW. Patterns of illegal drug use among an adult alcohol dependent population: results from the National Survey on Drug Use and Health. Drug Alcohol Depend. 2010;106(2–3):119–25. doi:10.1016/j.drugalcdep.2009.08.002.CrossRefPubMed

27.

Zacny JP, Drum M. Psychopharmacological effects of oxycodone in healthy volunteers: roles of alcohol-drinking status and sex. Drug Alcohol Depend. 2010;107(2–3):209–14. doi:10.1016/j.drugalcdep.2009.10.012.CrossRefPubMed

28.

Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology. 1997;129:99–111.CrossRefPubMed

29.

• Witkiewitz K, Vowles KE, McCallion E, Frohe T, Kirouac M, Maisto SA. Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE Study and the United Kingdom Alcohol Treatment Trial. Addiction. 2016;110(8):1262–71. doi:10.1111/add.12964.Pain. Pain is a signficant predictor of heavy drinking relapses during or after treatment, even after controlling for dependence severity, self-efficacy, temptation, psychiatric distress. CrossRef

30.

Almog YJ, Anglin MD, Fisher DG. Alcohol and heroin use patterns of narcotics addicts: gender and ethnic differences. Am J Drug Alcohol Abuse. 1993;19(2):219–38. doi:10.3109/00952999309002682.CrossRefPubMed

31.

Gossop M, Browne N, Stewart D, Marsden J. Alcohol use outcomes and heavy drinking at 4-5 years among a treatment sample of drug misusers. J Subst Abus Treat. 2003;25(3):135–43. doi:10.1016/S0740-5472(03)00129-6.CrossRef

32.

Gossop M, Ph D, Marsden J, et al. Patterns of drinking and drinking outcomes among drug misusers 1-year follow-up results. J Subst Abus Treat. 2000;19:45–50.CrossRef

33.

Staiger PK, Richardson B, Long CM, Carr V, Marlatt GA. Overlooked and underestimated? Problematic alcohol use in clients recovering from drug dependence. Addiction. 2012;108:1188–93. doi:10.1111/j.1360-0443.2012.04075.x.CrossRefPubMed

34.

Whelan PJ, Remski K. Buprenorphine vs methadone treatment : a review of evidence in both developed and developing worlds. J Neurosci Rural Pract. 2012;3(1):45–52. doi:10.4103/0976-3147.91934.CrossRefPubMedPubMedCentral

35.

Clark NC, Dietze P, Lenné MG, Redman JR. Effect of opioid substitution therapy on alcohol metabolism. J Subst Abus Treat. 2006;30(3):191–6. doi:10.1016/j.jsat.2005.11.010.CrossRef

36.

•• Nolan S, Klimas J, Wood E. Alcohol use in opioid agonist treatment. Addict Sci Clin Pract. 2016;11(17):1–7. doi:10.1186/s13722-016-0065-6. Review on alcohol use among individuals with opioid addiction. Findings show that indivdiuals with alcohol and opioid co-use have poorere treamtent outcomes, signfiicnatly increased morbidity and mortality, and report exacerbations of psychiatric comorbidities.

37.

Srivastava A, Kahan M, Ross S. The effect of methadone maintenance treatment on alcohol consumption: a systematic review. J Subst Abus Treat. 2008;34:215–23. doi:10.1016/j.jsat.2007.04.001.CrossRef

38.

Degenhardt L, Hall W. Patterns of co-morbidity between alcohol use and other substance use in the Australian population. Drug Alcohol Rev. 2003;22:7–13. doi:10.1080/0959523021000059776.CrossRefPubMed

39.

Zador D, Sunjic S. Deaths in methadone maintenenace treatment in New South Wales, Australia 1990–1995. Addiction. 2000;95(1):77–84.CrossRefPubMed

40.

Joseph H. Alcoholism and methadone treatment: consequences for the patient and program. Am J Drug Alcohol Abuse. 1985;11(1–2):37–53.CrossRefPubMed

41.

Senbanjo R, Wolff K, Marshall J. Excessive alcohol consumption is associated with reduced quality of life among methadone patients. Addiction. 2006;102:257–63. doi:10.1111/j.1360-0443.2006.01683.x.CrossRef

42.

Caldeiro RM, Malte CA, Calsyn DA, et al. The association of persistent pain with out-patient addiction treatment outcomes and service utilization. Addiction. 2008;103:1996–2005. doi:10.1111/j.1360-0443.2008.02358.x.CrossRefPubMed

43.

Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004;73(1):23–31. doi:10.1016/j.drugalcdep.2003.08.007.CrossRefPubMed

44.

Larson MJ, Paasche-orlow M, Cheng DM, Lloyd-travaglini C, Saitz R, Samet JH. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction. 2007;102:752–60. doi:10.1111/j.1360-0443.2007.01759.x.CrossRefPubMed

45.

Goebel JR, Compton P, Zubkoff L, et al. Prescription sharing, alcohol use, and street drug use to manage pain among veterans. J Pain Symptom Manag. 2016;41(5):848–58. doi:10.1016/j.jpainsymman.2010.07.009.CrossRef

46.

Savage SR. Addiction in the treatment of pain: significance, recognition, and management. J Pain Symptom Manag. 1993;8(5):265–78.CrossRef

47.

Morasco BJ, Gritzner S, Lewis L, Oldham R, Turk DC, Dobscha SK. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain. 2011;152(3):488–97. doi:10.1016/j.pain.2010.10.009.CrossRefPubMed

48.

Ilgen MA, Conner KR, Valenstein M, Austin K, Blow FC. Violent and nonviolent suicide in veterans with substance-use disorders. J Stud Alcohol Drugs. 2010;71(4):473–9.CrossRefPubMed

49.

Egli M, Koob GF, Edwards S. Neuroscience and biobehavioral reviews alcohol dependence as a chronic pain disorder. Neurosci Biobehav Rev. 2012;36(10):2179–92. doi:10.1016/j.neubiorev.2012.07.010.CrossRefPubMedPubMedCentral

50.

Weiss RD, Potter JS, Griffin ML, et al. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J Subst Abus Treat. 2014;47:140–5. doi:10.1016/j.jsat.2014.03.004.CrossRef

51.

•• Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165:179–87. Meta-analysis of treatment responses to psychosocial interventions among opioid, marijuana, cocaine, and polysubstance users. Polysubstance users and opioid users had the poorest treatment responses and outcomes. CrossRefPubMed

52.

Bowen S, Witkiewitz K, Clifasefi SL, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders a randomized clinical trial. JAMA Psychiatry. 2014;71(5):547–56. doi:10.1001/jamapsychiatry.2013.4546.CrossRefPubMedPubMedCentral

53.

Bowen S, Collins SE, Witkiewitz K, et al. Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Subst Abus. 2009;30:295–305. doi:10.1080/08897070903250084.CrossRefPubMedPubMedCentral

54.

Witkiewitz K, Warner K, Sully B, et al. Randomized trial comparing mindfulness-based relapse prevention addiction treatment center. Subst Use Misuse. 2014;49:536–46. doi:10.3109/10826084.2013.856922.CrossRefPubMed

Title: Co-use of Alcohol and Opioids
Authors: Karlyn A. Edwards
Kevin E. Vowles
Katie Witkiewitz
Publication date: 01-06-2017
Publisher: Springer International Publishing
Published in: Current Addiction Reports / Issue 2/2017
Electronic ISSN: 2196-2952
DOI: https://doi.org/10.1007/s40429-017-0147-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Co-use of Alcohol and Opioids

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 2/2017

‘Oxytocin Deficiency’: Implications for the Food-Addiction Construct

“Essentially, All Models Are Wrong, but Some Are Useful”: A Preliminary Conceptual Model of Co-occurring E-cig and Alcohol Use

Nutritional Aspects of Food Addiction

Cross-Cultural Effects of Cannabis Use Disorder: Evidence to Support a Cultural Neuroscience Approach

Longitudinal Studies on the Etiology of Cannabis Use Disorder: A Review

Cannabis Withdrawal: a Review of Neurobiological Mechanisms and Sex Differences